T3 Laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results

Clinical Otolaryngology & Allied Sciences

Volumn 17, Issue 5, 1992, Pages 393-402

  TERHAARD, C H J ^a   HORDIJK, G J ^a,i   BROEK, P VAN DEN ^d,i   JONG, P C DE ^f,g,i   SNOW, G B ^h   HILGERS, F J M ^e,i   ANNYAS, B A ^a   TJHO HESLINGA R E ^a,b   JONG, J M A DE ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c Institute of Limburg ^*  (Netherlands)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^e University of Dutch Cancer Institute ^*  (Netherlands)

^f UNIVERSITY OF GRONINGEN   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h VU UNIVERSITY AMSTERDAM   (Netherlands)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

clinical signs; laryngeal cancer; locoregional control; multiple primaries; salvage; survival; T3

Indexed keywords

ADULT; AGED; BRONCHUS TUMOR; CANCER STAGING; FEMALE; HUMAN; LARYNX TUMOR; LYMPH NODE METASTASIS; MALE; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PATHOLOGY; RETROSPECTIVE STUDY; REVIEW; SALVAGE THERAPY; SECOND CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR RECURRENCE; ARTICLE; BRONCHUS CANCER; CANCER CONTROL; CANCER RISK; CANCER SURVIVAL; DISEASE SEVERITY; LARYNX; LARYNX CANCER; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; METASTASIS; NETHERLANDS; PROGNOSIS; SEX RATIO; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; BRONCHIAL NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMAN; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE;

EID: 0026497856     PISSN: 03077772     EISSN: 13652273     Source Type: Journal    
DOI: 10.1111/j.1365-2273.1992.tb01681.x     Document Type: Article

References (45)

1. High dose pre‐operative radiotherapy and surgery for cancer of the larynx
2. High dose pre‐operative radiation and surgery for carcinoma of the larynx and laryngopharynx—a 14‐year program
3. Planned preoperative radiation therapy vs. definitive radiotherapy for advanced laryngeal carcinoma
4. The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers
5. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long‐term follow‐up of RTOG study 73‐03
6. Five‐year results of 100 patients operated on for cancer of the larynx
7. T3 glottic cancer: options and consequences of the options
8. Panel discussion on glottic tumours. IV. A statistical study of 620 laryngeal carcinomas of the glottic region personally operated upon more than five years ago
9. Radiation failures in cancer of the larynx
10. Partial laryngectomy for vocal cord cancer with marked limitation or fixation of the vocal cord
11. The treatment of T3 glottic carcinoma with vertical partial laryngectomy
12. Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx
13. Pre‐operative irradiation in the treatment of advanced laryngeal carcinoma
14. Management of T3 glottic cancer
15. Radiation therapy for advanced (T3T4NO‐3M0) laryngeal carcinoma: The need for a change of strategy: a radiotherapeutic viewpoint
16. Radiotherapy of cancer of the larynx
17. Twice‐a‐day radiotherapy for T3 squamous cell carcinoma of the glottic larynx
18. The management of glottic T3 carcinoma
19. Panel discussion on glottic tumours. VII The management of glottic carcinoma by primary irradiation with surgery in reserve
20. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx
21. Panel discussion on glottic tumours. VI Laryngeal carcinomas
22. Transglottic carcinoma
23. Significance and therapeutic implications of tumour regression following radiotherapy in patients treated for squamous cell carcinoma of the orphaynx and pharyngolarynx
24. Squamous cell carcinoma of the supraglottic larynx treated with radical irradiation: analysis of treatment parameters and results
25. Prognostic value of vocal cord fixation with respect to treatment in cancers of the supraglottis and pyriform sinus
26. Critical look at the TNM classification for laryngeal carcinoma
27. Local control in T3 laryngeal cancer treated with radical radiotherapy, time dose relationship: the concept of nominal standard dose and linear quadratic model
28. Prognostic factors in squamous cell carcinoma of the larynx
29. T3NOMO glottic carcinoma—a failure analysis
30. Prognostic factors in laryngeal carcinoma
31. Radiotherapeutic management of cancer of the supraglottis
32. Primary radiotherapy of larynx and pharynx carcinoma—an analysis of some factors influencing local control and survival
33. Ditferential effects of tobacco and alcohol in cancer of the larynx, pharynx and mouth
34. Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC International Case‐Control study in Turin and Varese (Italy), Zarogoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France)
35. Determants and prognosis of laryngeal cancer
36. The primary treatment of advanced vocal cord cancer: laryngectomy or radiotherapy
37. Patterns of cervical node metastases from squamous carcinoma of the larynx
38. Emergency laryngectomy and stomal recurrence
39. Stomal recurrence
40. Prognostic significance of lymphatic spread in head and neck carcinomas: therapeutic implications
41. Frequency and sites of distant metastases in head and neck squamous cell carcinoma, an analysis of 101 cases at autopsy
42. Hyperfrequency of pulmonary cancer in a population of 415 patients treated for laryngeal cancer
43. Multiple primary tumours in laryngeal cancer
44. The place of radiotherapy in the management of the squamous cell carcinoma of the supraglottic larynx